Oramed Pharmaceuticals Inc (ORMP): Kapitalflussrechnung
Kennzahl in 1000 USD | TTM 2025-03-31 | 2025-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2012-12-31 | 2011-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Umsatz | 2.000 | 2.000 | 1.340 | 2.703 | 2.703 | 2.710 | 2.703 | 2.449 | 2.456 | 641 | 184,254 | 197,412 |
Cashflow aus operativer Geschäftstätigkeit | -3.519 | -9.145 | -10.295 | -28.701 | -21.181 | -12.440 | -12.940 | -14.657 | -5.831 | 4.655 | -2.301,608 | -1.666,045 |
▸ Operative Cashflow Marge | -175,95% | -457,25% | -768,28% | -1.061,82% | -783,61% | -459,04% | -478,73% | -598,49% | -237,42% | 726,21% | -1.249,15% | -843,94% |
Investitionsausgaben (CapEx) | 2,999 | 1.933 | 253,999 | 495,999 | 374,999 | 81,999 | 14,999 | 4,999 | 6,999 | 9 | 2,132 | 2,175 |
Cashflow aus Investitionstätigkeit | 23.616 | 5.443 | -73.038 | 30.211 | -22.264 | 4.626 | 11.259 | -7.004 | 4.302 | -16.010 | 1.768,898 | -1.714,448 |
Cashflow aus Finanzierungstätigkeit | - | -4.741 | 51.978 | 11.562 | 101.392 | 23.786 | - | 22.654 | 1.586 | 12.043 | 3.488,942 | 3.694,212 |
Freier Cashflow | -3.521,999 | -11.078 | -10.548,999 | -29.196,999 | -21.555,999 | -12.521,999 | -12.954,999 | -14.661,999 | -5.837,999 | 4.646 | -2.303,74 | -1.668,22 |
▸ Freie Cashflow Marge | -176,1% | -553,9% | -787,24% | -1.080,17% | -797,48% | -462,07% | -479,28% | -598,69% | -237,7% | 724,8% | -1.250,31% | -845,04% |
Ausgeschüttete Dividenden | - | -10.870 | - | - | - | - | - | - | - | - | - | - |
Neuausgabe und Rückkäufe von Stammaktien | - | -4.741 | - | - | - | - | - | - | - | - | - | - |
Kennzahlen dieser Seite im Lexikon
Weitere Informationen findest du im Takani-Lexikon.